Novartis Recalls Tekturna HCT Physician Samples Due to Chemical Contamination
Novartis is recalling physician sample bottles of Tekturna HCT and other medications due to contamination with Darocur 1173, a photo-curing agent.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that may cause temporary or medically reversible adverse health consequences. The source text does not report any illnesses or injuries, and the hazard is a chemical contamination from packaging inks, fitting the criteria for a moderate severity score.
Plain-English summary
Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Tekturna HCT (aliskiren and hydrochlorothiazide) Tablets 150/12.5 mg. The recall also includes physician sample bottles of Diovan, Exforge, Exforge HCT, Lescol XL, and Stalevo. The affected Tekturna HCT bottles are identified by NDC # 0078-9521-89, Product Code 712396, and Lot Numbers F0026 and F0027, with an expiration date of 07/31/2014.
The recall was initiated due to chemical contamination with Darocur 1173, a photo-curing agent used in inks on shrink-wrap sleeves. The source text does not specify the exact quantity of Tekturna HCT bottles recalled, though the structured metadata indicates 16,693 bottles for this specific product code. The distribution pattern for the affected products is nationwide and Puerto Rico.
Consumers and healthcare providers should check their inventory for these specific lot numbers and product codes. If found, the products should be removed from use and returned to the distributor or recalled firm as directed by Novartis Pharmaceuticals Corporation.
The recalled product
- Product
- Tekturna HCT (aliskiren and hydrochlorothiazide) Tablets 150/12.5 mg, 7 tablets per bottle, Physician Sample-Not For Sale, Rx only, Manufactured by: Novartis Pharma Productions GmbH Wehr, Germany. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936 , ND
- Manufacturer
- Novartis Pharmaceuticals Corp.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 16,693
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Product code: 712396
- Lot Number: F0026
- F0027
- Exp 07/31/2014
Distribution
Part of a larger recall action
This product is one of 15 recalled by Novartis Pharmaceuticals Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 15 products in this recall →Related recalls
Same manufacturer · Novartis Pharmaceuticals Corp.
See all →- SevereNovartis Withdraws SANDIMMUNE Oral Solution Bottles Due to Crystallization
FDA (Drugs) · 2023-09-27
- CriticalNovartis Recalls Promacta Oral Suspension Due to Peanut Cross-Contamination
FDA (Drugs) · 2019-05-29
- ModerateNovartis Recalls Pilocarpine Hydrochloride Ophthalmic Solution for Impurity Failures
FDA (Drugs) · 2017-05-03
- LowNovartis Recalls Isopto Carpine Eye Drops for Impurity Failures
FDA (Drugs) · 2017-05-03
- LowNovartis Recalls Dexmethylphenidate HCl Extended-Release Capsules for Dissolution Failure
FDA (Drugs) · 2015-09-23
Same hazard · chemical contamination
See all →- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereGas-X Extra Strength softgels contaminated with propylene glycol machine coolant
FDA (Drugs) · 2026-06-17
- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22